MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$119,731K
Prepaid expenses and
other current assets
$1,658K
Total fixed assets
$5,200K
Total current assets
$121,389K
Lease right of use
assets
$1,661K
Fixed assets, net
$1,642K
Restricted cash
$416K
Other assets
$87K
Less accumulated
depreciation
$3,558K
Total assets
$125,195K
Total liabilities and
stockholders' equity
$125,195K
Total liabilities
$73,273K
Total stockholders'
equity
$51,922K
Accumulated deficit
-$230,387K
Treasury stock (at cost)
$448K
Term loans, net of
current portion
$46,122K
Warrant liabilities
$15,598K
Total current
liabilities
$8,997K
Lease liability, net
of current portion
$1,459K
Other long-term debt
$1,008K
Deferred revenue
$89K
Additional paid-in capital
$282,207K
Common stock, 0.01 par
value 150,000,000...
$550K
Accrued expenses
$7,334K
Accounts payable
$1,129K
Current portion of lease
liability
$445K
Other current
liabilities
$89K
Back
Back
Balance Sheet
source: myfinsight.com
Candel Therapeutics, Inc. (CADL)
Candel Therapeutics, Inc. (CADL)